|
|
Volumn 22, Issue 5, 2008, Pages 893-897
|
|
Meeting report: Myelodysplastic syndromes at ASH 2007
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE;
5 AZA 2' DEOXYCYTIDINE;
ALPHA CATENIN;
AZACITIDINE;
CD135 ANTIGEN;
CYTARABINE;
DNA POLYMERASE;
EARLY GROWTH RESPONSE FACTOR 1;
ERLOTINIB;
GEFITINIB;
IRON CHELATING AGENT;
JANUS KINASE 2;
LENALIDOMIDE;
LENTIVIRUS VECTOR;
MITOCHONDRIAL PROTEIN;
N (2 AMINOPHENYL) 4 [4 (3 PYRIDINYL) 2 PYRIMIDINYLAMINOMETHYL]BENZAMIDE;
NUCLEOPHOSMIN;
OSTEONECTIN;
PHOSPHOPROTEIN PHOSPHATASE 2A;
PROTEIN P53;
PROTEIN TYROSINE PHOSPHATASE;
RAS PROTEIN;
REMIPLISTIM;
RIBOSOME PROTEIN;
SHORT HAIRPIN RNA;
TRANSCRIPTION FACTOR RUNX1;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR SUPPRESSOR PROTEIN;
UNINDEXED DRUG;
VALPROIC ACID;
5Q- SYNDROME;
ACUTE GRANULOCYTIC LEUKEMIA;
ANEMIA;
APOPTOSIS;
CANCER SURVIVAL;
CARCINOGENESIS;
CELL DIFFERENTIATION;
CHROMOSOME 5Q;
CHROMOSOME 7Q;
CHROMOSOME ABERRATION;
CHROMOSOME DELETION 5;
CLINICAL TRIAL;
COMA;
COMPARATIVE GENOMIC HYBRIDIZATION;
CONFERENCE PAPER;
CONFUSION;
DISEASE MODEL;
DOSAGE SCHEDULE COMPARISON;
DRUG MECHANISM;
DRUG TOLERABILITY;
FLUORESCENCE IN SITU HYBRIDIZATION;
FUNCTIONAL GENOMICS;
GENE MUTATION;
GENETIC POLYMORPHISM;
HIGH RISK PATIENT;
HUMAN;
LOW DRUG DOSE;
MEDICAL DECISION MAKING;
MEDICAL SOCIETY;
MOLECULAR GENETICS;
MYELODYSPLASTIC SYNDROME;
NEUTROPENIA;
NONHUMAN;
OVERALL SURVIVAL;
PATHOGENESIS;
POINT MUTATION;
PRIORITY JOURNAL;
PROGNOSIS;
SINGLE NUCLEOTIDE POLYMORPHISM;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 43749102284
PISSN: 08876924
EISSN: 14765551
Source Type: Journal
DOI: 10.1038/leu.2008.45 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (22)
|
